Prelude Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123K Sell
14,451
-48,634
-77% -$324K 0.01% 1080
2026
Q1
$344K Buy
63,085
+2,485
+4% +$13.9K 0.03% 653
2025
Q4
$424K Sell
60,600
-108,889
-64% -$853K 0.03% 608
2025
Q3
$1.31M Buy
169,489
+156,547
+1,210% +$1.22M 0.1% 247
2025
Q2
$113K Buy
+12,942
New +$93.8K 0.01% 891
2025
Q1
Sell
-18,365
Closed -$167K 1519
2024
Q4
$167K Buy
+18,365
New +$177K 0.01% 1031
2024
Q3
Sell
-48,178
Closed -$471K 1533
2024
Q2
$471K Buy
48,178
+7,044
+17% +$85.9K 0.03% 567
2024
Q1
$621K Buy
41,134
+15,600
+61% +$283K 0.03% 540
2023
Q4
$550K Buy
+25,534
New +$471K 0.04% 475
2023
Q3
Sell
-11,338
Closed -$287K 1342
2023
Q2
$287K Sell
11,338
-862
-7% -$21.7K 0.02% 667
2023
Q1
$316K Sell
12,200
-1,269
-9% -$34K 0.02% 627
2022
Q4
$319K Buy
+13,469
New +$363K 0.02% 776
2021
Q1
Sell
-1,762
Closed -$352K 1806
2020
Q4
$352K Buy
+1,762
New +$358K 0.01% 848
2020
Q3
Sell
-5,877
Closed -$1.12M 2332
2020
Q2
$1.12M Buy
5,877
+5,177
+740% +$907K 0.06% 284
2020
Q1
$109K Buy
+700
New +$81.4K 0.01% 574

Other funds holding TDOC

Prelude Capital Management's TDOC Position: Q2 2026 in Review

Prelude Capital Management reduced its Teladoc Health (TDOC) stake by 77% in Q2 2026, selling an estimated $324K and leaving 14,451 shares worth $123K. The position accounts for 0.01% of the portfolio, ranked #1080.

Prelude Capital Management first reported a position in TDOC in Q1 2020 and has held it in 15 quarters since. The position peaked at $1.31M in Q3 2025. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Prelude Capital Management held 14,451 shares of Teladoc Health worth $123K as of Q2 2026.
  • Prelude Capital Management sold 48,634 Teladoc Health shares in Q2 2026, an estimated $324K.
  • Teladoc Health made up 0.01% of Prelude Capital Management's portfolio in Q2 2026, its #1080 holding.
  • Prelude Capital Management first reported a position in Teladoc Health in Q1 2020 and has held it in 15 quarters since.
  • Prelude Capital Management's Teladoc Health position peaked at $1.31M in Q3 2025.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.